Replies to post #179052 on Biotech Values

[DewDiligence]

RCPT curiosity: The link in #msg-95620474 (from Jan 2014) redirects to today’s PR!

[genisi]

Re: RCPT meets MS primary endpoint in phase-2 portion of trial

Will be interesting to see clinical trials data from other next generation S1P modulators, as there are differences between them regarding S1PR selectivity and potency and it remains to be determined which one has the best profile.